APO Research
Talk to an analyst

APO RESEARCH · REPORT

Skin Care Product Toxicology and Safety Testing

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Skin Care Product Toxicology and Safety Testing Market Outlook and Growth Opportunities 2026

6 March 2026203 pages

Choose your research edition.

Industry ResearchSkin Care Product Toxicology and Safety Testing Industry Research Report 2026129 pages · $2,950 USDIndustry Growth & TrendsGlobal Skin Care Product Toxicology and Safety Testing Industry Growth and Trends Forecast to 2032110 pages · $3,450 USDMarket StructureGlobal Skin Care Product Toxicology and Safety Testing Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Skin Care Product Toxicology and Safety Testing Market Outlook and Growth Opportunities 2026203 pages · $4,250 USDMarket Analysis & ForecastGlobal Skin Care Product Toxicology and Safety Testing Market Analysis and Forecast 2026-2032209 pages · $4,950 USD

Market perspective

The global Skin Care Product Toxicology and Safety Testing market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Skin Care Product Toxicology and Safety Testing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Skin Care Product Toxicology and Safety Testing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Skin Care Product Toxicology and Safety Testing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Skin Care Product Toxicology and Safety Testing market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Skin Care Product Toxicology and Safety Testing market include Charles River Laboratories, SGS, Intertek, QIMA Life Sciences, ACT Lab, CIRS GROUP, Bureau Veritas, TUV SUD and Eurofins, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Skin Care Product Toxicology and Safety Testing market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Skin Care Product Toxicology and Safety Testing and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Skin Care Product Toxicology and Safety Testing revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Skin Care Product Toxicology and Safety Testing market.

Skin Care Product Toxicology and Safety Testing Segment by Company

Charles River Laboratories

SGS

Intertek

QIMA Life Sciences

ACT Lab

CIRS GROUP

Bureau Veritas

TUV SUD

Eurofins

KOTITI

HQTS

TUV Rheinland

CMA Testing

Spectro Analytical Labs

Centre Testing International

Korea Testing & Research Institute

UL

Dekra

ALS Global

Skin Care Product Toxicology and Safety Testing Segment by Type

Irritation Test

Allergy Test

Phototoxicity Test

Others

Skin Care Product Toxicology and Safety Testing Segment by Application

Cosmetics Industry

Dermatology

Others

Skin Care Product Toxicology and Safety Testing Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Skin Care Product Toxicology and Safety Testing status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Skin Care Product Toxicology and Safety Testing key companies, revenue, market share, and recent developments.

3. To split the Skin Care Product Toxicology and Safety Testing breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Skin Care Product Toxicology and Safety Testing market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Skin Care Product Toxicology and Safety Testing significant trends, drivers, influence factors in global and regions.

6. To analyze Skin Care Product Toxicology and Safety Testing competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Skin Care Product Toxicology and Safety Testing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Skin Care Product Toxicology and Safety Testing and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Skin Care Product Toxicology and Safety Testing.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Skin Care Product Toxicology and Safety Testing industry.

Chapter 3: Detailed analysis of Skin Care Product Toxicology and Safety Testing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Skin Care Product Toxicology and Safety Testing in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Skin Care Product Toxicology and Safety Testing in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Skin Care Product Toxicology and Safety Testing Industry Trends Table 2. Skin Care Product Toxicology and Safety Testing Industry Drivers Table 3. Skin Care Product Toxicology and Safety Testing Industry Opportunities and Challenges Table 4. Skin Care Product Toxicology and Safety Testing Industry Restraints Table 5. Global Skin Care Product Toxicology and Safety Testing Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Skin Care Product Toxicology and Safety Testing Revenue Share by Company (2021-2026) Table 7. Global Skin Care Product Toxicology and Safety Testing Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Skin Care Product Toxicology and Safety Testing Key Company Manufacturing Base & Headquarters Table 9. Global Skin Care Product Toxicology and Safety Testing Company, Product Type & Application Table 10. Global Skin Care Product Toxicology and Safety Testing Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Skin Care Product Toxicology and Safety Testing by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Irritation Test Table 15. Significant Companies of Allergy Test Table 16. Significant Companies of Phototoxicity Test Table 17. Significant Companies of Others Table 18. Global Skin Care Product Toxicology and Safety Testing Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 19. Global Skin Care Product Toxicology and Safety Testing Sales Value by Type (2021-2026) & (US$ Million) Table 20. Global Skin Care Product Toxicology and Safety Testing Sales Value by Type (2027-2032) & (US$ Million) Table 21. Global Skin Care Product Toxicology and Safety Testing Sales Value Share by Type (2021-2026) Table 22. Global Skin Care Product Toxicology and Safety Testing Sales Value Share by Type (2027-2032) Table 23. Significant Companies of Cosmetics Industry Table 24. Significant Companies of Dermatology Table 25. Significant Companies of Others Table 26. Global Skin Care Product Toxicology and Safety Testing Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Skin Care Product Toxicology and Safety Testing Sales Value by Application (2021-2026) & (US$ Million) Table 28. Global Skin Care Product Toxicology and Safety Testing Sales Value by Application (2027-2032) & (US$ Million) Table 29. Global Skin Care Product Toxicology and Safety Testing Sales Value Share by Application (2021-2026) Table 30. Global Skin Care Product Toxicology and Safety Testing Sales Value Share by Application (2027-2032) Table 31. Global Skin Care Product Toxicology and Safety Testing Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Skin Care Product Toxicology and Safety Testing Sales Value by Region (2021-2026) & (US$ Million) Table 33. Global Skin Care Product Toxicology and Safety Testing Sales Value Share by Region (2021-2026) Table 34. Global Skin Care Product Toxicology and Safety Testing Sales Value by Region (2027-2032) & (US$ Million) Table 35. Global Skin Care Product Toxicology and Safety Testing Sales Value Share by Region (2027-2032) Table 36. Global Skin Care Product Toxicology and Safety Testing Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Skin Care Product Toxicology and Safety Testing Sales Value by Country (2021-2026) & (US$ Million) Table 38. Global Skin Care Product Toxicology and Safety Testing Sales Value Market Share by Country (2021-2026) Table 39. Global Skin Care Product Toxicology and Safety Testing Sales Value by Country (2027-2032) & (US$ Million) Table 40. Global Skin Care Product Toxicology and Safety Testing Sales Value Market Share by Country (2027-2032) Table 41. Charles River Laboratories Company Information Table 42. Charles River Laboratories Business Overview Table 43. Charles River Laboratories Skin Care Product Toxicology and Safety Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 44. Charles River Laboratories Skin Care Product Toxicology and Safety Testing Product Portfolio Table 45. Charles River Laboratories Recent Development Table 46. SGS Company Information Table 47. SGS Business Overview Table 48. SGS Skin Care Product Toxicology and Safety Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 49. SGS Skin Care Product Toxicology and Safety Testing Product Portfolio Table 50. SGS Recent Development Table 51. Intertek Company Information Table 52. Intertek Business Overview Table 53. Intertek Skin Care Product Toxicology and Safety Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 54. Intertek Skin Care Product Toxicology and Safety Testing Product Portfolio Table 55. Intertek Recent Development Table 56. QIMA Life Sciences Company Information Table 57. QIMA Life Sciences Business Overview Table 58. QIMA Life Sciences Skin Care Product Toxicology and Safety Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 59. QIMA Life Sciences Skin Care Product Toxicology and Safety Testing Product Portfolio Table 60. QIMA Life Sciences Recent Development Table 61. ACT Lab Company Information Table 62. ACT Lab Business Overview Table 63. ACT Lab Skin Care Product Toxicology and Safety Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 64. ACT Lab Skin Care Product Toxicology and Safety Testing Product Portfolio Table 65. ACT Lab Recent Development Table 66. CIRS GROUP Company Information Table 67. CIRS GROUP Business Overview Table 68. CIRS GROUP Skin Care Product Toxicology and Safety Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. CIRS GROUP Skin Care Product Toxicology and Safety Testing Product Portfolio Table 70. CIRS GROUP Recent Development Table 71. Bureau Veritas Company Information Table 72. Bureau Veritas Business Overview Table 73. Bureau Veritas Skin Care Product Toxicology and Safety Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. Bureau Veritas Skin Care Product Toxicology and Safety Testing Product Portfolio Table 75. Bureau Veritas Recent Development Table 76. TUV SUD Company Information Table 77. TUV SUD Business Overview Table 78. TUV SUD Skin Care Product Toxicology and Safety Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. TUV SUD Skin Care Product Toxicology and Safety Testing Product Portfolio Table 80. TUV SUD Recent Development Table 81. Eurofins Company Information Table 82. Eurofins Business Overview Table 83. Eurofins Skin Care Product Toxicology and Safety Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. Eurofins Skin Care Product Toxicology and Safety Testing Product Portfolio Table 85. Eurofins Recent Development Table 86. KOTITI Company Information Table 87. KOTITI Business Overview Table 88. KOTITI Skin Care Product Toxicology and Safety Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. KOTITI Skin Care Product Toxicology and Safety Testing Product Portfolio Table 90. KOTITI Recent Development Table 91. HQTS Company Information Table 92. HQTS Business Overview Table 93. HQTS Skin Care Product Toxicology and Safety Testing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 94. HQTS Skin Care Product Toxicology and Safety Testing Product Portfolio Table 95. HQTS Recent Development Table 96. TUV Rheinland Company Information Table 97. TUV Rheinland Business Overview Table 98. TUV Rheinland Skin Care Product Toxicology and Safety Testing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 99. TUV Rheinland Skin Care Product Toxicology and Safety Testing Product Portfolio Table 100. TUV Rheinland Recent Development Table 101. CMA Testing Company Information Table 102. CMA Testing Business Overview Table 103. CMA Testing Skin Care Product Toxicology and Safety Testing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 104. CMA Testing Skin Care Product Toxicology and Safety Testing Product Portfolio Table 105. CMA Testing Recent Development Table 106. Spectro Analytical Labs Company Information Table 107. Spectro Analytical Labs Business Overview Table 108. Spectro Analytical Labs Skin Care Product Toxicology and Safety Testing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 109. Spectro Analytical Labs Skin Care Product Toxicology and Safety Testing Product Portfolio Table 110. Spectro Analytical Labs Recent Development Table 111. Centre Testing International Company Information Table 112. Centre Testing International Business Overview Table 113. Centre Testing International Skin Care Product Toxicology and Safety Testing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 114. Centre Testing International Skin Care Product Toxicology and Safety Testing Product Portfolio Table 115. Centre Testing International Recent Development Table 116. Korea Testing & Research Institute Company Information Table 117. Korea Testing & Research Institute Business Overview Table 118. Korea Testing & Research Institute Skin Care Product Toxicology and Safety Testing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 119. Korea Testing & Research Institute Skin Care Product Toxicology and Safety Testing Product Portfolio Table 120. Korea Testing & Research Institute Recent Development Table 121. UL Company Information Table 122. UL Business Overview Table 123. UL Skin Care Product Toxicology and Safety Testing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 124. UL Skin Care Product Toxicology and Safety Testing Product Portfolio Table 125. UL Recent Development Table 126. Dekra Company Information Table 127. Dekra Business Overview Table 128. Dekra Skin Care Product Toxicology and Safety Testing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 129. Dekra Skin Care Product Toxicology and Safety Testing Product Portfolio Table 130. Dekra Recent Development Table 131. ALS Global Company Information Table 132. ALS Global Business Overview Table 133. ALS Global Skin Care Product Toxicology and Safety Testing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 134. ALS Global Skin Care Product Toxicology and Safety Testing Product Portfolio Table 135. ALS Global Recent Development Table 136. Research Programs/Design for This Report Table 137. Authors List of This Report Table 138. Secondary Sources Table 139. Primary Sources List of Figures Figure 1. Skin Care Product Toxicology and Safety Testing Product Image Figure 2. Global Skin Care Product Toxicology and Safety Testing Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Skin Care Product Toxicology and Safety Testing Market Size (2021-2032) & (US$ Million) Figure 4. Global Skin Care Product Toxicology and Safety Testing Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Irritation Test Image Figure 8. Allergy Test Image Figure 9. Phototoxicity Test Image Figure 10. Others Image Figure 11. Global Skin Care Product Toxicology and Safety Testing Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 12. Global Skin Care Product Toxicology and Safety Testing Sales Value Share 2021 VS 2025 VS 2032 Figure 13. Global Skin Care Product Toxicology and Safety Testing Sales Value Share by Type (2021-2032) Figure 14. Cosmetics Industry Image Figure 15. Dermatology Image Figure 16. Others Image Figure 17. Global Skin Care Product Toxicology and Safety Testing Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Skin Care Product Toxicology and Safety Testing Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global Skin Care Product Toxicology and Safety Testing Sales Value Share by Application (2021-2032) Figure 20. Global Skin Care Product Toxicology and Safety Testing Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 21. Global Skin Care Product Toxicology and Safety Testing Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 22. North America Skin Care Product Toxicology and Safety Testing Sales Value (2021-2032) & (US$ Million) Figure 23. North America Skin Care Product Toxicology and Safety Testing Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Europe Skin Care Product Toxicology and Safety Testing Sales Value (2021-2032) & (US$ Million) Figure 25. Europe Skin Care Product Toxicology and Safety Testing Sales Value Share by Country (%), 2025 VS 2032 Figure 26. Asia-Pacific Skin Care Product Toxicology and Safety Testing Sales Value (2021-2032) & (US$ Million) Figure 27. Asia-Pacific Skin Care Product Toxicology and Safety Testing Sales Value Share by Country (%), 2025 VS 2032 Figure 28. South America Skin Care Product Toxicology and Safety Testing Sales Value (2021-2032) & (US$ Million) Figure 29. South America Skin Care Product Toxicology and Safety Testing Sales Value Share by Country (%), 2025 VS 2032 Figure 30. Middle East & Africa Skin Care Product Toxicology and Safety Testing Sales Value (2021-2032) & (US$ Million) Figure 31. Middle East & Africa Skin Care Product Toxicology and Safety Testing Sales Value Share by Country (%), 2025 VS 2032 Figure 32. USA Skin Care Product Toxicology and Safety Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 33. USA Skin Care Product Toxicology and Safety Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 34. USA Skin Care Product Toxicology and Safety Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 35. Canada Skin Care Product Toxicology and Safety Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. Canada Skin Care Product Toxicology and Safety Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. Canada Skin Care Product Toxicology and Safety Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Mexico Skin Care Product Toxicology and Safety Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Mexico Skin Care Product Toxicology and Safety Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Mexico Skin Care Product Toxicology and Safety Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. Germany Skin Care Product Toxicology and Safety Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. Germany Skin Care Product Toxicology and Safety Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. Germany Skin Care Product Toxicology and Safety Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. France Skin Care Product Toxicology and Safety Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. France Skin Care Product Toxicology and Safety Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. France Skin Care Product Toxicology and Safety Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. U.K. Skin Care Product Toxicology and Safety Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. U.K. Skin Care Product Toxicology and Safety Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. U.K. Skin Care Product Toxicology and Safety Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Italy Skin Care Product Toxicology and Safety Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Italy Skin Care Product Toxicology and Safety Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Italy Skin Care Product Toxicology and Safety Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Spain Skin Care Product Toxicology and Safety Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Spain Skin Care Product Toxicology and Safety Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Spain Skin Care Product Toxicology and Safety Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Russia Skin Care Product Toxicology and Safety Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Russia Skin Care Product Toxicology and Safety Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Russia Skin Care Product Toxicology and Safety Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Netherlands Skin Care Product Toxicology and Safety Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Netherlands Skin Care Product Toxicology and Safety Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Netherlands Skin Care Product Toxicology and Safety Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Nordic Countries Skin Care Product Toxicology and Safety Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Nordic Countries Skin Care Product Toxicology and Safety Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Nordic Countries Skin Care Product Toxicology and Safety Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. China Skin Care Product Toxicology and Safety Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. China Skin Care Product Toxicology and Safety Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. China Skin Care Product Toxicology and Safety Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Japan Skin Care Product Toxicology and Safety Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Japan Skin Care Product Toxicology and Safety Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Japan Skin Care Product Toxicology and Safety Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. South Korea Skin Care Product Toxicology and Safety Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. South Korea Skin Care Product Toxicology and Safety Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. South Korea Skin Care Product Toxicology and Safety Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. India Skin Care Product Toxicology and Safety Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. India Skin Care Product Toxicology and Safety Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. India Skin Care Product Toxicology and Safety Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Australia Skin Care Product Toxicology and Safety Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Australia Skin Care Product Toxicology and Safety Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Australia Skin Care Product Toxicology and Safety Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Southeast Asia Skin Care Product Toxicology and Safety Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Southeast Asia Skin Care Product Toxicology and Safety Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Southeast Asia Skin Care Product Toxicology and Safety Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Brazil Skin Care Product Toxicology and Safety Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Brazil Skin Care Product Toxicology and Safety Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Brazil Skin Care Product Toxicology and Safety Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Argentina Skin Care Product Toxicology and Safety Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Argentina Skin Care Product Toxicology and Safety Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Argentina Skin Care Product Toxicology and Safety Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Chile Skin Care Product Toxicology and Safety Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Chile Skin Care Product Toxicology and Safety Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Chile Skin Care Product Toxicology and Safety Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Colombia Skin Care Product Toxicology and Safety Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Colombia Skin Care Product Toxicology and Safety Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Colombia Skin Care Product Toxicology and Safety Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Peru Skin Care Product Toxicology and Safety Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Peru Skin Care Product Toxicology and Safety Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Peru Skin Care Product Toxicology and Safety Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Skin Care Product Toxicology and Safety Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Saudi Arabia Skin Care Product Toxicology and Safety Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Saudi Arabia Skin Care Product Toxicology and Safety Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Israel Skin Care Product Toxicology and Safety Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Israel Skin Care Product Toxicology and Safety Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Israel Skin Care Product Toxicology and Safety Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. UAE Skin Care Product Toxicology and Safety Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. UAE Skin Care Product Toxicology and Safety Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. UAE Skin Care Product Toxicology and Safety Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Turkey Skin Care Product Toxicology and Safety Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Turkey Skin Care Product Toxicology and Safety Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Turkey Skin Care Product Toxicology and Safety Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Iran Skin Care Product Toxicology and Safety Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Iran Skin Care Product Toxicology and Safety Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Iran Skin Care Product Toxicology and Safety Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Egypt Skin Care Product Toxicology and Safety Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Egypt Skin Care Product Toxicology and Safety Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Egypt Skin Care Product Toxicology and Safety Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Years Considered Figure 117. Research Process Figure 118. Key Executives Interviewed

Scope & coverage.

Types
  • Irritation Test
  • Allergy Test
  • Phototoxicity Test
  • Others
Applications
  • Cosmetics Industry
  • Dermatology
  • Others
Companies covered
  • Charles River Laboratories
  • SGS
  • Intertek
  • QIMA Life Sciences
  • ACT Lab
  • CIRS GROUP
  • Bureau Veritas
  • TUV SUD
  • Eurofins
  • KOTITI
  • HQTS
  • TUV Rheinland
  • CMA Testing
  • Spectro Analytical Labs
  • Centre Testing International
  • Korea Testing & Research Institute
  • UL
  • Dekra
  • ALS Global

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Skin Care Product Toxicology and Safety Testing Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Skin Care Product Toxicology and Safety Testing Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Skin Care Product Toxicology and Safety Testing Market Dynamics
  1. 2.1 Skin Care Product Toxicology and Safety Testing Industry Trends
  2. 2.2 Skin Care Product Toxicology and Safety Testing Industry Drivers
  3. 2.3 Skin Care Product Toxicology and Safety Testing Industry Opportunities and Challenges
  4. 2.4 Skin Care Product Toxicology and Safety Testing Industry Restraints
3 Skin Care Product Toxicology and Safety Testing Market by Company
  1. 3.1 Global Skin Care Product Toxicology and Safety Testing Company Revenue Ranking in 2025
  2. 3.2 Global Skin Care Product Toxicology and Safety Testing Revenue by Company (2021-2026)
  3. 3.3 Global Skin Care Product Toxicology and Safety Testing Company Ranking (2024-2026)
  4. 3.4 Global Skin Care Product Toxicology and Safety Testing Company Manufacturing Base and Headquarters
  5. 3.5 Global Skin Care Product Toxicology and Safety Testing Company Product Type and Application
  6. 3.6 Global Skin Care Product Toxicology and Safety Testing Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Skin Care Product Toxicology and Safety Testing Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Skin Care Product Toxicology and Safety Testing Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Skin Care Product Toxicology and Safety Testing Market by Type
  1. 4.1 Skin Care Product Toxicology and Safety Testing Type Introduction
  2. 4.1.1 Irritation Test
  3. 4.1.2 Allergy Test
  4. 4.1.3 Phototoxicity Test
  5. 4.1.4 Others
  6. 4.2 Global Skin Care Product Toxicology and Safety Testing Sales Value by Type
  7. 4.2.1 Global Skin Care Product Toxicology and Safety Testing Sales Value by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Skin Care Product Toxicology and Safety Testing Sales Value by Type (2021-2032)
  9. 4.2.3 Global Skin Care Product Toxicology and Safety Testing Sales Value Share by Type (2021-2032)
5 Skin Care Product Toxicology and Safety Testing Market by Application
  1. 5.1 Skin Care Product Toxicology and Safety Testing Application Introduction
  2. 5.1.1 Cosmetics Industry
  3. 5.1.2 Dermatology
  4. 5.1.3 Others
  5. 5.2 Global Skin Care Product Toxicology and Safety Testing Sales Value by Application
  6. 5.2.1 Global Skin Care Product Toxicology and Safety Testing Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Skin Care Product Toxicology and Safety Testing Sales Value by Application (2021-2032)
  8. 5.2.3 Global Skin Care Product Toxicology and Safety Testing Sales Value Share by Application (2021-2032)
6 Skin Care Product Toxicology and Safety Testing Regional Value Analysis
  1. 6.1 Global Skin Care Product Toxicology and Safety Testing Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Skin Care Product Toxicology and Safety Testing Sales Value by Region (2021-2032)
  3. 6.2.1 Global Skin Care Product Toxicology and Safety Testing Sales Value by Region: 2021-2026
  4. 6.2.2 Global Skin Care Product Toxicology and Safety Testing Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Skin Care Product Toxicology and Safety Testing Sales Value (2021-2032)
  7. 6.3.2 North America Skin Care Product Toxicology and Safety Testing Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Skin Care Product Toxicology and Safety Testing Sales Value (2021-2032)
  10. 6.4.2 Europe Skin Care Product Toxicology and Safety Testing Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Skin Care Product Toxicology and Safety Testing Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Skin Care Product Toxicology and Safety Testing Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Skin Care Product Toxicology and Safety Testing Sales Value (2021-2032)
  16. 6.6.2 South America Skin Care Product Toxicology and Safety Testing Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Skin Care Product Toxicology and Safety Testing Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Skin Care Product Toxicology and Safety Testing Sales Value Share by Country, 2025 VS 2032
7 Skin Care Product Toxicology and Safety Testing Country-level Value Analysis
  1. 7.1 Global Skin Care Product Toxicology and Safety Testing Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Skin Care Product Toxicology and Safety Testing Sales Value by Country (2021-2032)
  3. 7.2.1 Global Skin Care Product Toxicology and Safety Testing Sales Value by Country (2021-2026)
  4. 7.2.2 Global Skin Care Product Toxicology and Safety Testing Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Skin Care Product Toxicology and Safety Testing Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Skin Care Product Toxicology and Safety Testing Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Skin Care Product Toxicology and Safety Testing Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Skin Care Product Toxicology and Safety Testing Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Skin Care Product Toxicology and Safety Testing Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Skin Care Product Toxicology and Safety Testing Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Skin Care Product Toxicology and Safety Testing Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Skin Care Product Toxicology and Safety Testing Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Skin Care Product Toxicology and Safety Testing Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Skin Care Product Toxicology and Safety Testing Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Skin Care Product Toxicology and Safety Testing Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Skin Care Product Toxicology and Safety Testing Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Skin Care Product Toxicology and Safety Testing Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Skin Care Product Toxicology and Safety Testing Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Skin Care Product Toxicology and Safety Testing Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Skin Care Product Toxicology and Safety Testing Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Skin Care Product Toxicology and Safety Testing Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Skin Care Product Toxicology and Safety Testing Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Skin Care Product Toxicology and Safety Testing Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Skin Care Product Toxicology and Safety Testing Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Skin Care Product Toxicology and Safety Testing Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Skin Care Product Toxicology and Safety Testing Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Skin Care Product Toxicology and Safety Testing Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Skin Care Product Toxicology and Safety Testing Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Skin Care Product Toxicology and Safety Testing Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Skin Care Product Toxicology and Safety Testing Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Skin Care Product Toxicology and Safety Testing Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Skin Care Product Toxicology and Safety Testing Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Skin Care Product Toxicology and Safety Testing Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Skin Care Product Toxicology and Safety Testing Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Skin Care Product Toxicology and Safety Testing Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Skin Care Product Toxicology and Safety Testing Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Skin Care Product Toxicology and Safety Testing Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Skin Care Product Toxicology and Safety Testing Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Skin Care Product Toxicology and Safety Testing Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Skin Care Product Toxicology and Safety Testing Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Skin Care Product Toxicology and Safety Testing Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Skin Care Product Toxicology and Safety Testing Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Skin Care Product Toxicology and Safety Testing Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Skin Care Product Toxicology and Safety Testing Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Skin Care Product Toxicology and Safety Testing Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Skin Care Product Toxicology and Safety Testing Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Skin Care Product Toxicology and Safety Testing Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Skin Care Product Toxicology and Safety Testing Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Skin Care Product Toxicology and Safety Testing Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Skin Care Product Toxicology and Safety Testing Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Skin Care Product Toxicology and Safety Testing Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Skin Care Product Toxicology and Safety Testing Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Skin Care Product Toxicology and Safety Testing Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Skin Care Product Toxicology and Safety Testing Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Skin Care Product Toxicology and Safety Testing Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Skin Care Product Toxicology and Safety Testing Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Skin Care Product Toxicology and Safety Testing Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Skin Care Product Toxicology and Safety Testing Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Skin Care Product Toxicology and Safety Testing Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Skin Care Product Toxicology and Safety Testing Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Skin Care Product Toxicology and Safety Testing Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Skin Care Product Toxicology and Safety Testing Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Skin Care Product Toxicology and Safety Testing Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Skin Care Product Toxicology and Safety Testing Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Skin Care Product Toxicology and Safety Testing Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Skin Care Product Toxicology and Safety Testing Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Skin Care Product Toxicology and Safety Testing Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Skin Care Product Toxicology and Safety Testing Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Skin Care Product Toxicology and Safety Testing Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Skin Care Product Toxicology and Safety Testing Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Skin Care Product Toxicology and Safety Testing Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Skin Care Product Toxicology and Safety Testing Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Skin Care Product Toxicology and Safety Testing Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Skin Care Product Toxicology and Safety Testing Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Skin Care Product Toxicology and Safety Testing Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Skin Care Product Toxicology and Safety Testing Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Skin Care Product Toxicology and Safety Testing Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Skin Care Product Toxicology and Safety Testing Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Skin Care Product Toxicology and Safety Testing Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Skin Care Product Toxicology and Safety Testing Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Skin Care Product Toxicology and Safety Testing Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Skin Care Product Toxicology and Safety Testing Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Skin Care Product Toxicology and Safety Testing Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Skin Care Product Toxicology and Safety Testing Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Skin Care Product Toxicology and Safety Testing Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Skin Care Product Toxicology and Safety Testing Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Skin Care Product Toxicology and Safety Testing Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Skin Care Product Toxicology and Safety Testing Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Charles River Laboratories
  2. 8.1.1 Charles River Laboratories Company Information
  3. 8.1.2 Charles River Laboratories Business Overview
  4. 8.1.3 Charles River Laboratories Skin Care Product Toxicology and Safety Testing Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Charles River Laboratories Skin Care Product Toxicology and Safety Testing Product Portfolio
  6. 8.1.5 Charles River Laboratories Recent Developments
  7. 8.2 SGS
  8. 8.2.1 SGS Company Information
  9. 8.2.2 SGS Business Overview
  10. 8.2.3 SGS Skin Care Product Toxicology and Safety Testing Revenue and Gross Margin (2021-2026)
  11. 8.2.4 SGS Skin Care Product Toxicology and Safety Testing Product Portfolio
  12. 8.2.5 SGS Recent Developments
  13. 8.3 Intertek
  14. 8.3.1 Intertek Company Information
  15. 8.3.2 Intertek Business Overview
  16. 8.3.3 Intertek Skin Care Product Toxicology and Safety Testing Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Intertek Skin Care Product Toxicology and Safety Testing Product Portfolio
  18. 8.3.5 Intertek Recent Developments
  19. 8.4 QIMA Life Sciences
  20. 8.4.1 QIMA Life Sciences Company Information
  21. 8.4.2 QIMA Life Sciences Business Overview
  22. 8.4.3 QIMA Life Sciences Skin Care Product Toxicology and Safety Testing Revenue and Gross Margin (2021-2026)
  23. 8.4.4 QIMA Life Sciences Skin Care Product Toxicology and Safety Testing Product Portfolio
  24. 8.4.5 QIMA Life Sciences Recent Developments
  25. 8.5 ACT Lab
  26. 8.5.1 ACT Lab Company Information
  27. 8.5.2 ACT Lab Business Overview
  28. 8.5.3 ACT Lab Skin Care Product Toxicology and Safety Testing Revenue and Gross Margin (2021-2026)
  29. 8.5.4 ACT Lab Skin Care Product Toxicology and Safety Testing Product Portfolio
  30. 8.5.5 ACT Lab Recent Developments
  31. 8.6 CIRS GROUP
  32. 8.6.1 CIRS GROUP Company Information
  33. 8.6.2 CIRS GROUP Business Overview
  34. 8.6.3 CIRS GROUP Skin Care Product Toxicology and Safety Testing Revenue and Gross Margin (2021-2026)
  35. 8.6.4 CIRS GROUP Skin Care Product Toxicology and Safety Testing Product Portfolio
  36. 8.6.5 CIRS GROUP Recent Developments
  37. 8.7 Bureau Veritas
  38. 8.7.1 Bureau Veritas Company Information
  39. 8.7.2 Bureau Veritas Business Overview
  40. 8.7.3 Bureau Veritas Skin Care Product Toxicology and Safety Testing Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Bureau Veritas Skin Care Product Toxicology and Safety Testing Product Portfolio
  42. 8.7.5 Bureau Veritas Recent Developments
  43. 8.8 TUV SUD
  44. 8.8.1 TUV SUD Company Information
  45. 8.8.2 TUV SUD Business Overview
  46. 8.8.3 TUV SUD Skin Care Product Toxicology and Safety Testing Revenue and Gross Margin (2021-2026)
  47. 8.8.4 TUV SUD Skin Care Product Toxicology and Safety Testing Product Portfolio
  48. 8.8.5 TUV SUD Recent Developments
  49. 8.9 Eurofins
  50. 8.9.1 Eurofins Company Information
  51. 8.9.2 Eurofins Business Overview
  52. 8.9.3 Eurofins Skin Care Product Toxicology and Safety Testing Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Eurofins Skin Care Product Toxicology and Safety Testing Product Portfolio
  54. 8.9.5 Eurofins Recent Developments
  55. 8.10 KOTITI
  56. 8.10.1 KOTITI Company Information
  57. 8.10.2 KOTITI Business Overview
  58. 8.10.3 KOTITI Skin Care Product Toxicology and Safety Testing Revenue and Gross Margin (2021-2026)
  59. 8.10.4 KOTITI Skin Care Product Toxicology and Safety Testing Product Portfolio
  60. 8.10.5 KOTITI Recent Developments
  61. 8.11 HQTS
  62. 8.11.1 HQTS Company Information
  63. 8.11.2 HQTS Business Overview
  64. 8.11.3 HQTS Skin Care Product Toxicology and Safety Testing Revenue and Gross Margin (2021-2026)
  65. 8.11.4 HQTS Skin Care Product Toxicology and Safety Testing Product Portfolio
  66. 8.11.5 HQTS Recent Developments
  67. 8.12 TUV Rheinland
  68. 8.12.1 TUV Rheinland Company Information
  69. 8.12.2 TUV Rheinland Business Overview
  70. 8.12.3 TUV Rheinland Skin Care Product Toxicology and Safety Testing Revenue and Gross Margin (2021-2026)
  71. 8.12.4 TUV Rheinland Skin Care Product Toxicology and Safety Testing Product Portfolio
  72. 8.12.5 TUV Rheinland Recent Developments
  73. 8.13 CMA Testing
  74. 8.13.1 CMA Testing Company Information
  75. 8.13.2 CMA Testing Business Overview
  76. 8.13.3 CMA Testing Skin Care Product Toxicology and Safety Testing Revenue and Gross Margin (2021-2026)
  77. 8.13.4 CMA Testing Skin Care Product Toxicology and Safety Testing Product Portfolio
  78. 8.13.5 CMA Testing Recent Developments
  79. 8.14 Spectro Analytical Labs
  80. 8.14.1 Spectro Analytical Labs Company Information
  81. 8.14.2 Spectro Analytical Labs Business Overview
  82. 8.14.3 Spectro Analytical Labs Skin Care Product Toxicology and Safety Testing Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Spectro Analytical Labs Skin Care Product Toxicology and Safety Testing Product Portfolio
  84. 8.14.5 Spectro Analytical Labs Recent Developments
  85. 8.15 Centre Testing International
  86. 8.15.1 Centre Testing International Company Information
  87. 8.15.2 Centre Testing International Business Overview
  88. 8.15.3 Centre Testing International Skin Care Product Toxicology and Safety Testing Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Centre Testing International Skin Care Product Toxicology and Safety Testing Product Portfolio
  90. 8.15.5 Centre Testing International Recent Developments
  91. 8.16 Korea Testing & Research Institute
  92. 8.16.1 Korea Testing & Research Institute Company Information
  93. 8.16.2 Korea Testing & Research Institute Business Overview
  94. 8.16.3 Korea Testing & Research Institute Skin Care Product Toxicology and Safety Testing Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Korea Testing & Research Institute Skin Care Product Toxicology and Safety Testing Product Portfolio
  96. 8.16.5 Korea Testing & Research Institute Recent Developments
  97. 8.17 UL
  98. 8.17.1 UL Company Information
  99. 8.17.2 UL Business Overview
  100. 8.17.3 UL Skin Care Product Toxicology and Safety Testing Revenue and Gross Margin (2021-2026)
  101. 8.17.4 UL Skin Care Product Toxicology and Safety Testing Product Portfolio
  102. 8.17.5 UL Recent Developments
  103. 8.18 Dekra
  104. 8.18.1 Dekra Company Information
  105. 8.18.2 Dekra Business Overview
  106. 8.18.3 Dekra Skin Care Product Toxicology and Safety Testing Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Dekra Skin Care Product Toxicology and Safety Testing Product Portfolio
  108. 8.18.5 Dekra Recent Developments
  109. 8.19 ALS Global
  110. 8.19.1 ALS Global Company Information
  111. 8.19.2 ALS Global Business Overview
  112. 8.19.3 ALS Global Skin Care Product Toxicology and Safety Testing Revenue and Gross Margin (2021-2026)
  113. 8.19.4 ALS Global Skin Care Product Toxicology and Safety Testing Product Portfolio
  114. 8.19.5 ALS Global Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst